SEIDENBERG BETH C
Insider CIK 1184592 · SGMT Director · TSRO Director · PGNY Director · EPZM Director, 10% owner · ATRA Director, 10% owner · ARMO Director, 10% owner · VERA Director · SLRN Director, 10% owner · KYTX Director, 10% owner · LTGO Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 165,519 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 2,066,857 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,547,842 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,027,635 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,464,072 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 938,979 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,547,842 | — | $0 | 4,916,374 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 938,979 | — | $0 | 1,368,532 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,027,635 | — | $0 | 5,944,009 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,464,072 | — | $0 | 3,510,927 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,484,401 | — | $0 | 4,995,328 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 165,519 | — | $0 | 5,160,847 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 2,066,857 | — | $0 | 2,094,813 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 165,519 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 2,066,857 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,484,401 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,464,072 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,027,635 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 3,547,842 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-10 | 938,979 | — | — | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 2,066,857 | — | — | 2,094,813 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 165,519 | — | — | 5,160,847 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,484,401 | — | — | 4,995,328 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,464,072 | — | — | 3,510,927 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 1,027,635 | — | — | 5,944,009 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 3,547,842 | — | — | 4,916,374 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-10 | 938,979 | — | — | 1,368,532 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2026-06-12 | 2026-06-15 | 39,567 | — | $0 | 39,567 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2026-05-27 | 2026-05-29 | 20,582 | — | $0 | 20,582 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2026-05-27 | 2026-05-29 | 5,093 | — | $0 | 21,727 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 17,084 | — | $0 | 17,084 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | P Buy | 2025-12-18 | 2025-12-22 | 133,333 | $7.50 | $1000.0K | 869,317 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2025-06-09 | 2025-06-10 | 32,250 | — | $0 | 32,250 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 28,522 | — | $0 | 28,522 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-06-02 | 65,351 | — | $0 | 65,351 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | A Award | 2025-05-29 | 2025-06-02 | 16,634 | — | $0 | 16,634 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 92,158 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 9,790,729 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 60,000 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-05-14 | 2025-05-16 | 14,000 | — | $0 | 14,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 202 | $49.54 | $10.0K | 131,553 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 14,798 | $48.01 | $710.5K | 131,755 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-09-19 | 2024-09-20 | 13,823 | $42.31 | $584.9K | 146,553 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-09-18 | 2024-09-20 | 1,476 | $42.00 | $62.0K | 4,012 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2024-09-18 | 2024-09-20 | 1,177 | $42.01 | $49.4K | 160,376 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 92,158 | — | $0 | 92,158 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 51,459 | — | $0 | 51,459 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 26,926 | — | $0 | 26,926 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2024-05-23 | 2024-05-28 | 7,206 | — | $0 | 43,416 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 14,000 | — | $0 | 14,000 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 3,349,538 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 4,401,771 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 8,830,901 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 4,006,624 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion | 2024-02-12 | 2024-02-14 | 735,984 | — | $0 | 735,984 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion | 2024-02-12 | 2024-02-14 | 3,787,940 | — | $0 | 3,787,940 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 6,737,254 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 6,103,580 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 8,596,589 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 8,596,590 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 493,370 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 539,006 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award deriv | 2023-07-18 | 2023-07-20 | 23,216 | — | $0 | 23,216 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | D To issuer deriv | 2023-07-18 | 2023-07-20 | 23,216 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 20,430,107 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion deriv | 2023-07-18 | 2023-07-20 | 103,127,234 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | P Buy | 2023-07-18 | 2023-07-20 | 46,875 | $16.00 | $750.0K | 46,875 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | D To issuer | 2023-07-18 | 2023-07-20 | 38,763 | — | $0 | 0 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | A Award | 2023-07-18 | 2023-07-20 | 38,763 | — | $0 | 38,763 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion | 2023-07-18 | 2023-07-20 | 1,860,712 | — | $0 | 1,899,475 | SEC↗ |
| SGMT Sagimet Biosciences Inc. | C Conversion | 2023-07-18 | 2023-07-20 | 84,768 | — | $0 | 84,768 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-23 | 2023-06-27 | 10,284 | — | $0 | 36,210 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-23 | 2023-06-27 | 17,162 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-09 | 2023-06-13 | 247,446 | — | $0 | 17,162 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-09 | 2023-06-13 | 264,608 | — | $0 | 264,608 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-09 | 2023-06-13 | 1,398,900 | — | $0 | 5,074,615 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2023-06-09 | 2023-06-13 | 6,656 | — | $0 | 25,926 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2023-05-31 | 2023-06-02 | 79,500 | — | $0 | 79,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2023-05-31 | 2023-06-02 | 57,000 | — | $0 | 115,689 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2023-05-24 | 2023-06-01 | 3,261 | $19.93 | $65.0K | 3,261 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2023-05-24 | 2023-06-01 | 19,709 | — | $0 | 19,709 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2023-05-24 | 2023-06-01 | 5,116 | — | $0 | 19,270 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | C Conversion deriv | 2023-05-09 | 2023-05-11 | 4,056,795 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | C Conversion deriv | 2023-05-09 | 2023-05-11 | 2,445,786 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | C Conversion deriv | 2023-05-09 | 2023-05-11 | 2,038,148 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 23,243 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 1,250,000 | $18.00 | $22.50M | 9,790,729 | SEC↗ |
| SLRN ACELYRIN, Inc. | C Conversion | 2023-05-09 | 2023-05-11 | 8,540,729 | — | $0 | 8,540,729 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 60,000 | $18.00 | $1.08M | 60,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 23,243 | — | $0 | 23,243 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-30 | 2023-04-03 | 2,300 | $7.24 | $16.7K | 1,949,295 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-28 | 2023-03-30 | 23,908 | $7.24 | $173.1K | 1,946,995 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-27 | 2023-03-28 | 1,633 | $7.24 | $11.8K | 1,923,087 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-24 | 2023-03-28 | 1,833 | $7.24 | $13.3K | 1,921,454 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-20 | 2023-03-21 | 15,252 | $7.21 | $110.0K | 1,919,621 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-17 | 2023-03-21 | 74,045 | $7.12 | $527.2K | 1,904,369 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-16 | 2023-03-17 | 60,097 | $7.09 | $426.1K | 1,830,324 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-15 | 2023-03-17 | 32,844 | $7.12 | $233.8K | 1,770,227 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-10 | 2023-03-14 | 48,003 | $7.16 | $343.7K | 1,737,383 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-03 | 2023-03-07 | 1,000 | $7.25 | $7.3K | 1,689,380 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-02 | 2023-03-03 | 23,378 | $7.24 | $169.3K | 1,688,380 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-03-01 | 2023-03-03 | 100 | $7.25 | $725 | 1,665,002 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-23 | 2023-02-27 | 200 | $7.24 | $1.4K | 1,664,902 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-13 | 2023-02-15 | 10,072 | $7.20 | $72.5K | 1,664,702 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-09 | 2023-02-13 | 400 | $7.25 | $2.9K | 1,654,630 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-08 | 2023-02-09 | 45,357 | $7.22 | $327.5K | 1,654,230 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-07 | 2023-02-09 | 87,956 | $7.08 | $622.7K | 1,608,873 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-06 | 2023-02-09 | 131,602 | $7.03 | $925.2K | 1,520,917 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-03 | 2023-02-09 | 46,163 | $7.24 | $334.2K | 1,389,315 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 1,898 | — | $0 | 1,898 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2022-10-24 | 2022-10-26 | 16,820 | — | $0 | 16,820 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2022-10-24 | 2022-10-26 | 4,060 | — | $0 | 14,154 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-06-23 | 2022-06-27 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-06-23 | 2022-06-27 | 20,500 | — | $0 | 58,689 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2022-05-24 | 2022-05-26 | 9,925 | — | $0 | 9,925 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2022-03-03 | 2022-10-26 | 22,999 | — | $0 | 227,906 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2022-03-03 | 2022-10-26 | 22,999 | — | $0 | 10,094 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-12-22 | 2021-12-27 | 19,265 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-12-22 | 2021-12-27 | 15,250 | — | $0 | 33,093 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-11-17 | 2021-11-18 | 306,560 | — | $0 | 306,560 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-11-17 | 2021-11-18 | 7,749 | — | $0 | 17,843 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-11-17 | 2021-11-18 | 287,295 | — | $0 | 19,265 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-11-17 | 2021-11-18 | 932,600 | — | $0 | 6,473,515 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2021-10-24 | 2021-10-26 | 2,813 | — | $0 | 2,813 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2021-10-24 | 2021-10-26 | 17,003 | — | $0 | 17,003 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2021-10-24 | 2021-10-26 | 3,094 | — | $0 | 10,094 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2021-09-16 | 2021-10-26 | 32,802 | — | $0 | 7,000 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-07-19 | 2021-07-21 | 20,994 | — | $0 | 39,802 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-07-19 | 2021-07-21 | 29,494 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-06-21 | 2021-06-23 | 1,398,900 | — | $0 | 7,406,115 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-06-21 | 2021-06-23 | 437,921 | — | $0 | 29,494 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-06-21 | 2021-06-23 | 467,415 | — | $0 | 467,415 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-06-21 | 2021-06-23 | 11,808 | — | $0 | 18,808 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-06-08 | 2021-06-09 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-06-08 | 2021-06-09 | 11,000 | — | $0 | 38,189 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2021-05-27 | 2021-06-23 | 84,964 | — | $0 | 172,105 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2021-05-27 | 2021-06-23 | 84,964 | — | $0 | 7,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 818,984 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 100,526 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 423,642 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 100,526 | — | $0 | 524,168 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 818,984 | — | $0 | 1,343,152 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 423,642 | — | $0 | 423,642 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2021-05-13 | 2021-05-17 | 9,925 | — | $0 | 9,925 | SEC↗ |
| PGNY Progyny, Inc. | X Exercise deriv | 2021-04-15 | 2021-04-19 | 284,998 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | X Exercise deriv | 2021-04-15 | 2021-04-19 | 242,248 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | X Exercise | 2021-04-15 | 2021-04-19 | 242,248 | $1.73 | $419.1K | 8,538,144 | SEC↗ |
| PGNY Progyny, Inc. | X Exercise | 2021-04-15 | 2021-04-19 | 284,998 | $1.73 | $493.0K | 8,823,142 | SEC↗ |
| PGNY Progyny, Inc. | S Sale | 2021-04-15 | 2021-04-19 | 9,799 | $50.32 | $493.1K | 8,805,015 | SEC↗ |
| PGNY Progyny, Inc. | S Sale | 2021-04-15 | 2021-04-19 | 8,328 | $50.32 | $419.1K | 8,814,814 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-03-30 | 2021-04-01 | 49,877 | — | $0 | 91,964 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-03-30 | 2021-04-01 | 90,310 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-22 | 2021-01-26 | 13,158 | — | $0 | 42,087 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-22 | 2021-01-26 | 489,038 | — | $0 | 90,310 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-22 | 2021-01-26 | 522,904 | — | $0 | 579,348 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-22 | 2021-01-26 | 1,398,900 | — | $0 | 8,295,896 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2021-01-11 | 2021-01-26 | 87,141 | — | $0 | 28,929 | SEC↗ |
| PGNY Progyny, Inc. | G Gift | 2021-01-11 | 2021-01-26 | 87,141 | — | $0 | 87,141 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-07 | 2021-01-11 | 522,904 | — | $0 | 545,482 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-07 | 2021-01-11 | 13,157 | — | $0 | 116,070 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-07 | 2021-01-11 | 489,038 | — | $0 | 56,444 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2021-01-07 | 2021-01-11 | 1,398,900 | — | $0 | 9,694,796 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-12-30 | 2021-01-04 | 326,025 | — | $0 | 22,578 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-12-30 | 2021-01-04 | 348,603 | — | $0 | 348,603 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-12-30 | 2021-01-04 | 8,772 | — | $0 | 102,913 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-12-30 | 2021-01-04 | 932,600 | — | $0 | 11,093,696 | SEC↗ |
| PGNY Progyny, Inc. | S Sale | 2020-12-14 | 2020-12-15 | 38,461 | $42.00 | $1.62M | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-30 | 2020-12-02 | 1,398,900 | — | $0 | 12,026,296 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-30 | 2020-12-02 | 24,238 | — | $0 | 94,141 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-30 | 2020-12-02 | 522,904 | — | $0 | 522,904 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-30 | 2020-12-02 | 522,904 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | S Sale | 2020-11-27 | 2020-12-01 | 19,231 | $36.00 | $692.3K | 38,461 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-13 | 2020-11-17 | 1,398,900 | — | $0 | 13,425,196 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-13 | 2020-11-17 | 35,798 | — | $0 | 69,903 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-13 | 2020-11-17 | 593,197 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-11-13 | 2020-11-17 | 522,904 | — | $0 | 593,197 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-10-27 | 2,325 | $27.95 | $65.0K | 2,325 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-10-27 | 29,000 | — | $0 | 29,000 | SEC↗ |
| PGNY Progyny, Inc. | A Award deriv | 2020-10-24 | 2020-11-20 | 4,799 | — | $0 | 4,799 | SEC↗ |
| PGNY Progyny, Inc. | A Award | 2020-10-24 | 2020-10-27 | 7,000 | — | $0 | 34,105 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-08-19 | 2020-08-24 | 27,105 | — | $0 | 27,105 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-08-19 | 2020-08-24 | 1,078,340 | — | $0 | 1,078,340 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-08-19 | 2020-08-24 | 1,008,047 | — | $0 | 70,293 | SEC↗ |
| PGNY Progyny, Inc. | J Other | 2020-08-19 | 2020-08-24 | 2,797,800 | — | $0 | 14,824,096 | SEC↗ |
| PGNY Progyny, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 19,231 | $30.00 | $576.9K | 57,692 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-06-16 | 2020-06-17 | 24,500 | — | $0 | 24,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-06-16 | 2020-06-17 | 8,000 | — | $0 | 27,189 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 284,998 | — | $0 | 284,998 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 284,998 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 242,248 | — | $0 | 242,248 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 242,248 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 6,149,084 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-30 | 10,753,784 | — | $0 | 0 | SEC↗ |
| PGNY Progyny, Inc. | P Buy | 2019-10-29 | 2019-10-30 | 76,923 | $13.00 | $1000.0K | 76,923 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 10,753,784 | — | $0 | 17,621,896 | SEC↗ |
| PGNY Progyny, Inc. | C Conversion | 2019-10-29 | 2019-10-30 | 6,149,084 | — | $0 | 6,868,112 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-06-30 | 2019-07-02 | 1,010 | $12.55 | $12.7K | 8,481 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-06-27 | 2019-07-01 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-06-27 | 2019-07-01 | 4,000 | — | $0 | 19,189 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-03-31 | 2019-06-07 | 1,024 | $12.39 | $12.7K | 7,471 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 4,052 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-24 | 7,209 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 1,994,768 | $75.00 | $149.61M | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 45,907 | $75.00 | $3.44M | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 10,998 | $75.00 | $824.9K | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 868 | $75.00 | $65.1K | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 168,755 | $75.00 | $12.66M | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-24 | 868 | $75.00 | $65.1K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2018-07-02 | 2018-07-02 | 3,247 | $13.55 | $44.0K | 6,447 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 4,266,683 | $50.00 | $213.33M | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-06-14 | 2018-06-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-06-14 | 2018-06-18 | 1,500 | — | $0 | 15,189 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 4,052 | — | $0 | 4,052 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 7,209 | — | $0 | 7,209 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2018-06-01 | 2018-06-05 | 1,332 | — | $0 | 45,907 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 326,242 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 403,097 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 673,173 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,212,494 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,296,248 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 355,429 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 4,266,683 | — | $0 | 4,266,683 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-12-14 | 2017-12-15 | 13,219 | — | $0 | 10,998 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 58,500 | — | $0 | 168,755 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 204,166 | — | $0 | 204,166 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 204,166 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 22,516 | — | $0 | 44,575 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 663 | — | $0 | 868 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 663 | — | $0 | 868 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2017-09-11 | 2017-09-11 | 667,283 | — | $0 | 2,018,985 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2017-06-08 | 2017-06-12 | 5,000 | — | $0 | 13,689 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2017-06-01 | 2017-06-05 | 402 | — | $0 | 22,059 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2017-01-03 | 2017-01-05 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2017-01-03 | 2017-01-05 | 2,000 | — | $0 | 8,689 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2016-07-01 | 2016-07-06 | 3,200 | $10.33 | $33.1K | 3,200 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,269 | — | $0 | 21,657 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2016-03-18 | 2016-03-18 | 1,310,031 | $35.19 | $46.10M | 2,686,268 | SEC↗ |
| TSRO TESARO, Inc. | P Buy | 2016-03-18 | 2016-03-18 | 110,827 | $35.19 | $3.90M | 227,255 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2016-01-04 | 2016-01-05 | 10,500 | — | $0 | 10,500 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-12-16 | 2016-02-17 | 8,652 | — | $0 | 1,376,237 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-12-16 | 2016-02-17 | 315 | — | $0 | 20,388 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-12-16 | 2015-12-17 | 2,996 | — | $0 | 6,689 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-12-16 | 2015-12-17 | 4,716 | — | $0 | 4,716 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-09-17 | 2015-09-21 | 267,948 | — | $0 | 1,384,889 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-09-17 | 2015-09-21 | 3,562 | — | $0 | 20,073 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-09-17 | 2015-09-21 | 205 | — | $0 | 205 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-09-17 | 2015-09-21 | 205 | — | $0 | 205 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2015-09-17 | 2015-09-21 | 23,400 | — | $0 | 116,428 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 291,300 | — | $0 | 1,822,228 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 197 | — | $0 | 197 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 43,518 | — | $0 | 4,716 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 48,234 | — | $0 | 48,234 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 8,700 | — | $0 | 54,422 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 197 | — | $0 | 197 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-09-17 | 2015-09-21 | 3,693 | — | $0 | 3,693 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2015-07-08 | 2015-07-10 | 7,333 | — | $0 | 7,333 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2015-06-01 | 2015-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2015-06-01 | 2015-06-03 | 946 | — | $0 | 16,511 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-05-19 | 2015-05-21 | 291,300 | — | $0 | 2,113,528 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-05-19 | 2015-05-21 | 8,700 | — | $0 | 63,122 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-05-14 | 2015-05-18 | 71,822 | — | $0 | 71,822 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | J Other | 2015-05-14 | 2015-05-18 | 194,200 | — | $0 | 2,404,828 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2015-01-16 | 2015-01-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 18,136 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 1,244,871 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 607,234 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 37,179 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-23 | 1,852,106 | — | $0 | 2,599,029 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-23 | 55,314 | — | $0 | 77,621 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2014-07-23 | 2014-07-25 | 7,333 | — | $0 | 7,333 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2014-06-02 | 2014-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2014-06-02 | 2014-06-04 | 2,238 | — | $0 | 15,565 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 388,584 | $27.64 | $10.74M | 3,838,167 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 6,462,918 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2013-06-05 | 2013-06-07 | 17,666 | — | $0 | 17,666 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 6,217,335 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 2,072,445 | — | $0 | 4,226,751 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 2,154,306 | — | $0 | 2,154,306 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2013-06-03 | 2013-06-05 | 10,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2013-06-03 | 2013-06-05 | 1,006 | — | $0 | 13,327 | SEC↗ |
| TSRO TESARO, Inc. | J Other | 2013-05-28 | 2013-05-29 | 9,325 | — | $0 | 12,321 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2012-10-15 | 2012-10-17 | 2,996 | — | $0 | 2,996 | SEC↗ |